www.scmp.com

www.scmp.com
Share

www.scmp.com

 •  May 14

Investors should play it safe when it comes to Chinese drug makers as the sector is going through a major transition despite buoyant stock prices and positive net profit growth last year, an analyst from US broker Jefferies has warned. China’s pharmaceutical market – the world’s second largest after the US – showed “steady growth” in 2016, with...

www.scmp.com

 •  February 14

The global pharmaceutical industry spends about US$50 billion a year on research and development. Thanks to its growing expertise in clinical trials, Hong Kong is gearing up to take a larger slice of it. A combination of global regulatory changes and growing local competency has catapulted the city forward. In 2004, 221 clinical trials were...

www.scmp.com

 •  February 14

Greece has enough medicine to last three to four months and drugmakers said that they would continue supplying the country for now, despite increased financial uncertainty after Greeks rejected austerity terms of a bailout. The pharmaceuticals industry is owed more than €1.1 billion (HK$9.4 billion) by Greek hospitals and the state-run health...

www.scmp.com

 •  February 14

Japan's health ministry said yesterday it was probing claims falsified data was used in an Alzheimer's disease study involving major drug makers. Health officials said they were questioning researchers after being told false data was used in clinical testing for the US$28 million, government-backed Alzheimer's study, aimed at improving diagnosis of...